B Canaud1, M Morena, J P Cristol
1Nephrology, Dialysis and Intensive Care Unit, Lapeyronie University Hospital, Montpellier, France. b-canaud@chu-montpellier.fr
Beta-2 microglobulin (β2M) is a key indicator of hemodialysis patient health and dialysis effectiveness. Monitoring β2M may reveal that longer, daily hemodiafiltration treatments are optimal for improving patient outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: